Journal
JOURNAL OF NEUROCHEMISTRY
Volume 111, Issue 1, Pages 242-249Publisher
WILEY
DOI: 10.1111/j.1471-4159.2009.06320.x
Keywords
Alzheimer's disease; diabetes mellitus; glucose transporter; human brain; O-GlcNAcylation; tau phosphorylation
Categories
Funding
- New York State Office of Mental Retardation and Developmental Disabilities
- NIH [AG027429, AG019158]
- US Alzheimer's Association [NIRG-08-91126]
- National Institute on Aging [P30 AG19610]
Ask authors/readers for more resources
Type 2 diabetes mellitus (T2DM) increases the risk for Alzheimer's disease (AD), but the underlying mechanism is unknown. In this study, we determined the levels of major brain glucose transporters, O-GlcNAcylation and phosphorylation of tau in the postmortem brain tissue from frontal cortices of 7 controls, 11 T2DM subjects, 10 AD subjects and 8 additional subjects who had both T2DM and AD. We found that the neuronal glucose transporter 3 was decreased to a bigger extent in T2DM brain than in AD brain. The O-GlcNAcylation levels of global proteins and of tau were also decreased in T2DM brain as seen in AD brain. Phosphorylation of tau at some of the AD abnormal hyperphosphorylation sites was increased in T2DM brain. These results suggest that T2DM may contribute to the increased risk for AD by impairing brain glucose uptake/metabolism and, consequently, down-regulation of O-GlcNAcylation, which facilitates abnormal hyperphosphorylation of tau.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available